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The title compound, C10H5ClF3N, crystallizes with two almost
identical molecules in the asymmetric unit. Geometric
parameters are in the usual ranges. The crystal packing is
characterized by C—H  N weak hydrogen bonds and –
stacking interactions.
Comment
Quinolines have been interesting to researchers for many
years because a large number of natural products contain
these heterocycles. They are found in numerous commericial
products, including pharmaceuticals, fragrances and dyes
(Padwa et al., 1999). Quinoline alkaloids such as quinine,
chloroquin, mefloquine and amodiaquine are used as efficient
drugs for the treatment of malaria (Robert & Meunier, 1998).
Quinoline has been reported to have excellent antibiotic
properties. Papaverine is an opium alkaloid, which is a non-
specific smooth muscle relaxant and vasodilator (Gilchrist,
1997). In recent years, fluorinated compounds have been very
important in the pharmaceutical field. Incorporation of an F
atom instead of an H atom can alter the course of the reaction
as well as biological activities. Introduction of further F atoms
in a CF3 group provides better lipophilicity and the
compounds might be pharmacologically more interesting
compared to their non-fluorinated analogues. Trifluoromethyl-
substituted compounds have been reported to possess
biological activities as herbicides (Bravo et al., 1994), fungi-
cides (Jung et al., 2002) and inhibitors for platelet aggregation
(Ku¨c¸u¨kgu¨zel et al., 2000). Several quinoline derivatives have
been evaluated in vitro against several parasites and HTLV-1
transformed cells (Franck et al., 2004). 7-(Trifluoromethyl)-
quinoline derivatives have been evaluated for in vitro activity
against some parasites in blood (Abadi & Brun, 2003).
Prompted by the varied biological activities, the crystal
structure of the title compound, (I), is reported.
A perspective view of the title compound is shown in Fig. 1.
Bond lengths and angles can be regarded as normal
(Cambridge Structural Database, Version 5.27, November
2005 update, August 2006; MOGUL, Version 1.1; Allen, 2002).
The two molecules in the asymmetric unit are almost identical
(r.m.s. deviation for all non-H atoms 0.022 A˚). The crystal
packing shows stacks of molecules (Fig. 2). The two symmetry-
independent molecules are almost parallel [angle between the
planes of the aromatic atoms = 2.33 (4)]. The distances in a
stack are (Cg = centre of gravity): Cg(C5–
10)  Cg(N1A,C2A–C6A) 3.825 A˚, Cg(N1A, C2A–
C6A)  Cgi(N1A, C2A–C6A) 3.610 A˚ [symmetry code: (i)
1  x, 1  y, 2  z]. In addition to these – interactions, the
molecules are linked by weak C—H  N hydrogen bonds
(Table 1).
Experimental
The title compound was obtained as a gift sample from Strides Arco
Laboratories, Mangalore, India. The sample was crystallized from a
toluene–acetone (1:1) mixture by slow evaporation (m.p. 354–355 K).
Crystal data
C10H5ClF3N
Mr = 231.60
Monoclinic, P21=n
a = 10.3179 (11) A˚
b = 12.4319 (10) A˚
c = 14.5673 (17) A˚
 = 95.023 (9)
V = 1861.4 (3) A˚3
Z = 8
Dx = 1.653 Mg m
3
Mo K radiation
 = 0.42 mm1
T = 173 (2) K
Block, colourless
0.49  0.49  0.48 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 2003;
Blessing, 1995)
Tmin = 0.822, Tmax = 0.825
11382 measured reflections
3486 independent reflections
2655 reflections with I > 2(I)
Rint = 0.042
max = 25.6

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.037
wR(F 2) = 0.105
S = 1.06
3486 reflections
272 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0578P)2
+ 0.4196P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.001
max = 0.34 e A˚
3
min = 0.29 e A˚3
Extinction correction: SHELXL97
Extinction coefficient: 0.0089 (11)
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C3A—H3A  N1i 0.95 2.61 3.546 (3) 168
C3—H3  N1Aii 0.95 2.81 3.669 (3) 151
Symmetry codes: (i) xþ 32; y 12;zþ 32; (ii) x þ 12; yþ 12;zþ 32.
H atoms were found in a difference map, but they were reposi-
tioned geometrically and refined using a riding model, with C—H =
0.95 A˚ and Uiso(H) = 1.2Ueq(C).
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement: X-
AREA; data reduction: X-AREA; program(s) used to solve structure:
SHELXS97 (Sheldrick, 199); program(s) used to refine structure:
SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97.
MP and TVS thank Mangalore University for access to
research facilities.
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Figure 1
The asymmetric unit of the title compound, showing the atom numbering
and displacement ellipsoids drawn at the 50% probability level.
Figure 2
Packing diagram of the title compound, viewed perpendicular to the bc
plane. H atoms have been omitted for clarity.
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